N1VO34:BVMF
Novo Nordisk Bdr
23,92 R$
0,00%
(0,00) 1 d.
13. okt., 16:56:00 GMT-3 · BRL
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: N1VO34…
Atvērt
24,01 R$
Augsta
24,36 R$
Zema
23,80 R$
Tirgus kapitalizācija
128,51 mljrd.
Vid. apjoms
34,82 tūkst.
Apjoms
8,45 tūkst.
Augstākā 52 ned.
42,43 R$
Zemākā 52 ned.
22,90 R$
Apgrozībā esošās akcijas
3,39 mljrd.
Darbinieku skaits
67 tūkst.
Atvērt
24,01 R$
Augsta
24,36 R$
Zema
23,80 R$
Tirgus kapitalizācija
128,51 mljrd.
Vid. apjoms
34,82 tūkst.
Apjoms
8,45 tūkst.
Augstākā 52 ned.
42,43 R$
Zemākā 52 ned.
22,90 R$
Apgrozībā esošās akcijas
3,39 mljrd.
Darbinieku skaits
67 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Traders Union
·
pirms 7 stundām
India emerges as a key hub in pharmaceutical companies’ anti-obesity business and research strategy
The Motley Fool
·
pirms 13 stundām
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
TipRanks
·
pirms 1 dienas
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
Yahoo Finance
·
pirms 1 dienas
Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
Profils
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Par “Novo Nordisk Bdr”
ĢenerāldirektorsMaziar Mike Doustdar
Darbinieki66,7 tūkst.
Dibināšanas datums1923
Galvenais birojsBagsværd, Galvaspilsētas reģions, Dānija
Sektors-
Tīmekļa vietnenovonordisk.com